Proposed Data Collection Submitted for Public Comment and Recommendations, 46994-46996 [2017-21752]
Download as PDF
<![CDATA[
46994
Federal Register / Vol. 82, No. 194 / Tuesday, October 10, 2017 / Notices
of care for stroke, and improve
transitions across stroke systems of care,
including pre-event; transitions from
EMS to acute care in hospitals; and
transitions from hospitals to home,
rehabilitation, stroke specialist care, and
primary care providers.
When Congress directed the Centers
for Disease Control and Prevention
(CDC) to establish the Paul Coverdell
National Acute Stroke Program
(PCNASP) in 2001, CDC intended to
monitor trends in stroke and stroke care,
with the ultimate mission of improving
the quality of care for stroke patients in
the United States. Since 2015, CDC has
funded and provided technical
assistance to nine state health
departments to develop comprehensive
stroke systems of care. A comprehensive
system of care improves quality of care
by creating seamless transitions for
individuals experiencing stroke. In such
a system, pre-hospital providers, inhospital providers, and early posthospital providers coordinate patient
hand-offs and ensure continuity of care.
CDC contracted with RTI International
to conduct a national evaluation of the
state health departments awarded grants
Cost data collection will focus on a
stratified sample of partners’ cumulative
spending to support PCNASP activities,
spending by reporting period, and
spending associated with specific
PCNASP strategies related to building
comprehensive state-wide stroke
systems of care. Interview questions will
target how each grantee implemented its
strategies, challenges encountered and
how they were overcome, factors that
facilitated implementation, lessons
learned along the way, and observed
outcomes and improvements.
The information to be collected does
not currently exist for large scale,
statewide programs that employ
multiple combinations of strategies led
by state public health departments to
build comprehensive stroke systems of
care. The insights to be gained from this
data collection will be critical to
improving immediate efforts and
achieving the goals of spreading and
replicating state-level strategies that are
proven programmatically and are costeffective in contributing to a higher
quality of care for stroke patients.
in 2015 to assess their implementation
in their state-based contexts and
progress toward short- and
intermediate-term outcomes.
CDC and RTI International propose to
collect information from all nine funded
PCNASP grantees to gain insight into
the effectiveness of implementation of
their quality improvement strategies,
development (and use) of a data
integrated management system, and
partner collaboration in building
comprehensive state-wide stroke
systems of care. The information
collection will focus on describing
PCNASP specific contributions to
effective state-based stroke systems of
care and the costs associated with this
work.
Two components of the information
collection include: (1) Program
implementation cost data collection
from program partners using a cost and
resource utilization tool; and (2)
telephone interviews with key program
stakeholders, such as the PCNASP
principal investigator, program
manager, quality improvement
specialist, data analyst/program
evaluator, and partner support staff.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondent
Form name
Partner Program Manager ................
Principal Investigator .........................
Grantee Program Manager ...............
Quality Improvement Specialist ........
Data Analyst/Program Evaluator .......
Partner Support Staff ........................
Cost Resource and Utilization Tool
Telephonic Interviews ......................
Telephonic Interviews ......................
Telephonic Interviews ......................
Telephonic Interviews ......................
Telephonic Interviews ......................
205
9
9
9
9
18
2
1
1
1
1
1
2
1
1
1
1
1
820
9
9
9
9
18
Total ...........................................
..........................................................
........................
........................
........................
874
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–21751 Filed 10–6–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–1071; Docket No. CDC–2017–
0087]
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
sradovich on DSK3GMQ082PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
SUMMARY:
VerDate Sep<11>2014
17:26 Oct 06, 2017
Jkt 244001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery. In order to
work continuously to ensure that our
programs are effective and meet our
customers’ needs, the National Center
for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention (CDC) seeks to obtain
Office of Management and Budget
approval of a generic information
collection request to collect qualitative
feedback on our service delivery.
DATES: CDC must receive written
comments on or before December 11,
2017.
E:\FR\FM\10OCN1.SGM
10OCN1
46995
Federal Register / Vol. 82, No. 194 / Tuesday, October 10, 2017 / Notices
You may submit comments,
identified by Docket No. CDC–2017–
0087 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov. Please note: Submit all
Federal comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
ADDRESSES:
programs are effective and meet our
customers’ needs, the National Center
for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention (CDC) (hereafter the
‘‘Agency’’) seeks to obtain OMB
approval of a generic clearance to
collect qualitative feedback on our
service delivery. By qualitative feedback
we mean information that provides
useful insights on perceptions and
opinions, but are not statistical surveys
that yield quantitative results that can
be generalized to the population of
study.
This collection of information is
necessary to enable the Agency to garner
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with our commitment to
improving service delivery. The
information collected from our
customers and stakeholders will help
ensure that users have an effective,
efficient, and satisfying experience with
the Agency’s programs. This feedback
will provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Since gaining approval in June 2015,
NCEZID has utilized 16,800 responses
and 2,029, burden hours for nine
separate information collection projects.
There is no cost to respondents other
than the time to participate.
Authorizing legislation comes from
Section 301 of the Public Health Service
Act (42 U.S.C. 241).
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Generic Clearance for the Collection
of Qualitative Feedback on Agency
Service Delivery (OMB Control Number
0920–1071, Expires 6/30/2018)—
Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC/NCEZID is seeking a three-year
extension of OMB Control Number
0920–1071 to continue collecting
routine customer feedback on agency
service delivery.
Executive Order 12862 directs Federal
agencies to provide service to the public
that matches or exceeds the best service
available in the private sector. In order
to work continuously to ensure that our
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
General public ...................................
sradovich on DSK3GMQ082PROD with NOTICES
Type of respondents
Online surveys .................................
Focus groups ...................................
In-person surveys .............................
Usability testing ................................
Customer comment cards ................
1,500
800
1,000
1,500
1,000
1
1
1
1
1
30/60
2
30/60
30/60
15/60
750
1,600
500
750
250
Total ...........................................
...........................................................
........................
........................
........................
3,850
VerDate Sep<11>2014
17:26 Oct 06, 2017
Jkt 244001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\10OCN1.SGM
10OCN1
46996
Federal Register / Vol. 82, No. 194 / Tuesday, October 10, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–21752 Filed 10–6–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-17–17AZI; Docket No. CDC–2017–
0075]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed study titled
‘‘Understanding Decisions and Barriers
about PrEP Use and Uptake among Men
Who Have Sex with Men.’’ This study
will provide insight on individual and
community level PrEP-related decisionmaking, and identify barriers and
facilitators to successful PrEP initiation
and PrEP acceptability.
DATES: CDC must receive written
comments on or before December 11,
2017.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2017–
0075 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all Federal
comments through the Federal
sradovich on DSK3GMQ082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:26 Oct 06, 2017
Jkt 244001
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Understanding Decisions and Barriers
about PrEP Use and Uptake among Men
Who Have Sex With Men—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Background and Brief Description
This project involves original,
formative research toward improving
the uptake and adherence necessary to
achieve efficacious levels of protection
offered by pre-exposure prophylaxis
(PrEP) among the most affected
population. HIV incidence and
prevalence are higher among gay,
bisexual, and other men who have sex
with men (MSM) than any other risk
group in the U.S. Approximately half of
all diagnosed HIV infections are among
gay, bisexual, and other MSM. The
FDA-approved PrEP regimen, daily
Tenofovir/emtricitabine (aka Truvada®),
has shown greater than 90% efficacy in
reducing HIV infections among MSM
when taken in accordance with its
prescribed daily schedule. In 2014, CDC
published clinical practice guidelines
for the use of PrEP in high-risk
populations, and began national
promotion of PrEP as an effective HIV
prevention strategy for MSM. While
hailed as an HIV-prevention ‘‘gamechanger,’’ in reality PrEP uptake has
been slow. Some studies report a wide
range in the percentages of MSM (28–
81%) interested in PrEP. In addition,
other studies indicate that specific cities
have alarmingly low rates of PrEP
uptake (for example, the estimate for
Atlanta is 2%). Moreover, recent survey
findings have shown that less than 1 in
10 MSM on PrEP are adherent to their
PrEP regimen; adherence is necessary to
optimize efficacy.
In order to develop effective programs
that increase PrEP uptake among MSM
at greatest risk for HIV, studies are
needed to better understand the
decisions men make about their HIV
prevention needs. Qualitative methods
will be used to explore in-depth the
‘‘Whys’’ and ‘‘How’s’’ of MSM’s
decisions to refuse or use PrEP, and
barriers and challenges to successfully
undertake a PrEP medication regimen.
Quantitative methods will be used to
understand the HIV risk behavior
context, attitudes towards PrEP, health
seeking behavior, and acceptability of
new modes of PrEP delivery (that differ
from current recommendation of daily
PrEP and that are in development or
discussion) and emerging biomedical
HIV prevention options.
The purpose of this research is to
explore decisions, barriers, and
facilitators about PrEP use among MSM:
(1) Who were offered PrEP but refused
it; (2) who were interested in or started
a PrEP regimen but did not follow
through; and (3) who are eligible for
PrEP per CDC guidelines (report
condomless anal sex within last 3
months).
E:\FR\FM\10OCN1.SGM
10OCN1
]]>Agencies
[Federal Register Volume 82, Number 194 (Tuesday, October 10, 2017)]
[Notices]
[Pages 46994-46996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21752]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-1071; Docket No. CDC-2017-0087]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Generic Clearance for the
Collection of Qualitative Feedback on Agency Service Delivery. In order
to work continuously to ensure that our programs are effective and meet
our customers' needs, the National Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease Control and Prevention (CDC)
seeks to obtain Office of Management and Budget approval of a generic
information collection request to collect qualitative feedback on our
service delivery.
DATES: CDC must receive written comments on or before December 11,
2017.
[[Page 46995]]
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0087 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov. Please note: Submit all Federal comments through
the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Generic Clearance for the Collection of Qualitative Feedback on
Agency Service Delivery (OMB Control Number 0920-1071, Expires 6/30/
2018)--Extension--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC/NCEZID is seeking a three-year extension of OMB Control Number
0920-1071 to continue collecting routine customer feedback on agency
service delivery.
Executive Order 12862 directs Federal agencies to provide service
to the public that matches or exceeds the best service available in the
private sector. In order to work continuously to ensure that our
programs are effective and meet our customers' needs, the National
Center for Emerging and Zoonotic Infectious Diseases, Centers for
Disease Control and Prevention (CDC) (hereafter the ``Agency'') seeks
to obtain OMB approval of a generic clearance to collect qualitative
feedback on our service delivery. By qualitative feedback we mean
information that provides useful insights on perceptions and opinions,
but are not statistical surveys that yield quantitative results that
can be generalized to the population of study.
This collection of information is necessary to enable the Agency to
garner customer and stakeholder feedback in an efficient, timely
manner, in accordance with our commitment to improving service
delivery. The information collected from our customers and stakeholders
will help ensure that users have an effective, efficient, and
satisfying experience with the Agency's programs. This feedback will
provide insights into customer or stakeholder perceptions, experiences
and expectations, provide an early warning of issues with service, or
focus attention on areas where communication, training or changes in
operations might improve delivery of products or services. These
collections will allow for ongoing, collaborative and actionable
communications between the Agency and its customers and stakeholders.
It will also allow feedback to contribute directly to the improvement
of program management.
Since gaining approval in June 2015, NCEZID has utilized 16,800
responses and 2,029, burden hours for nine separate information
collection projects.
There is no cost to respondents other than the time to participate.
Authorizing legislation comes from Section 301 of the Public Health
Service Act (42 U.S.C. 241).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
General public................ Online surveys.. 1,500 1 30/60 750
Focus groups.... 800 1 2 1,600
In-person 1,000 1 30/60 500
surveys.
Usability 1,500 1 30/60 750
testing.
Customer comment 1,000 1 15/60 250
cards.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,850
----------------------------------------------------------------------------------------------------------------
[[Page 46996]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-21752 Filed 10-6-17; 8:45 am]
BILLING CODE 4163-18-P
